[Treatment protocol for secondary prevention in patients with coronary heart disease].
Rubinstein
A
A
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000924:Anticholesteremic Agents / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D003327:Coronary Disease / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy*; D006293:Health Promotion; D006801:Humans; D008077:Lipoproteins, LDL / Q000097:blood
D000806:Angiotensin-Converting Enzyme Inhibitors; D000924:Anticholesteremic Agents; D000959:Antihypertensive Agents; D008077:Lipoproteins, LDL